Details of issuance or disposal
Report on the large-scale exercise of the 35th Stock Acquisition Rights issued through a third-party allotment (with exercise price adjustment clause)
Shares delivered since the beginning of the month: 1,496,500 shares (new shares: 1,496,500; transferred treasury shares: 0)
Shares delivered since the beginning of the month: 1,496,500 shares (approximately 2.10%), against 71,307,500 shares outstanding
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
| Item | Details |
|---|---|
| Type of issuance or disposal | Report on the large-scale exercise of the 35th Stock Acquisition Rights issued through a third-party allotment (with exercise price adjustment clause) |
| Number of shares to be issued or disposed of | Shares delivered since the beginning of the month: 1,496,500 shares (new shares: 1,496,500; transferred treasury shares: 0) |
| Intended allottee | グロース・キャピタル株式会社 (allottee of these Stock Acquisition Rights) |
| Dilution Rate | Shares delivered since the beginning of the month: 1,496,500 shares (approximately 2.10%), against 71,307,500 shares outstanding |
| Total number of issued shares | 71,307,500 shares (as of the end of the month preceding the subject month) → Not disclosed |
| Exercise price | ¥44 (2, 4, 5 and 6 November), ¥37 (9, 10, 11 and 12 November). Exercise price adjustment provisions apply. The adjustment floor is Not disclosed. |
| Number of Stock Acquisition Rights | Total issued: 147,820 warrants; exercised since the beginning of the month: 14,965; unexercised at the beginning of the month: 28,396; unexercised at present: 13,431 |
| Most recent equity financing | Series 35 warrants issued on 5 June 2026 through a third-party allotment, with exercise price adjustment provisions. Amount: Not disclosed. |
Items this document does not state (20)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To report the substantial exercise to investors. No individual reasons for exercise or use of proceeds are stated.